2/12
02:02 pm
upb
Upstream Bio: Hold Rating As Verekitug Faces Competition Among Latest Asthma Data [Seeking Alpha]
Low
Report
Upstream Bio: Hold Rating As Verekitug Faces Competition Among Latest Asthma Data [Seeking Alpha]
2/11
06:00 am
upb
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
High
Report
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
2/10
06:52 pm
upb
Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma [Yahoo! Finance]
High
Report
Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma [Yahoo! Finance]
2/10
06:00 pm
upb
Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma
High
Report
Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma
1/8
12:20 pm
upb
Upstream Bio: Fully Priced After Recent Rally [Seeking Alpha]
Low
Report
Upstream Bio: Fully Priced After Recent Rally [Seeking Alpha]
1/5
07:00 am
upb
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/19
05:59 am
upb
Upstream Bio (NASDAQ:UPB) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Medium
Report
Upstream Bio (NASDAQ:UPB) was upgraded by analysts at Mizuho to a "strong-buy" rating.
12/17
07:01 pm
upb
Upstream Bio (NASDAQ:UPB) was given a new $51.00 price target on by analysts at Mizuho.
Medium
Report
Upstream Bio (NASDAQ:UPB) was given a new $51.00 price target on by analysts at Mizuho.
2/11
09:17 am
upb
Form 8-K Upstream Bio, Inc. For: Feb 11
High
Report
Form 8-K Upstream Bio, Inc. For: Feb 11
2/11
06:39 am
upb
Form 8-K Upstream Bio, Inc. For: Feb 11
High
Report
Form 8-K Upstream Bio, Inc. For: Feb 11
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Houghton Adam
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Houghton Adam
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Deykin Aaron
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Deykin Aaron
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Sutherland Everett Rand
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Sutherland Everett Rand
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: GRAY MICHAEL
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: GRAY MICHAEL
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Ambrose Allison
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Ambrose Allison
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register